Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: Clin Cancer Res. 2021 Feb 16;27(9):2481–2493. doi: 10.1158/1078-0432.CCR-20-3944

Table 1.

Summary of mIHC quantification for matched lesions at screening and EOS

Patient Treated CD8+ at S (cells/mm2) CD8+ at EOS (cells/mm2) Fold change to CD8s CD163+ at S (cells/mm2) CD163+ at EOS (cells/mm2) Ratio at S CD8/CD163 Ratio at EOS CD8/CD163 Fold change CD8:CD163 FoxP3+ at S (cells/mm2) FoxP3+ at EOS (cells/mm2) Ratio at S CD8/FoxP3 Ratio at EOS CD8/FoxP3 Fold change CD8:FoxP3 Total PD-L1 at S (cells/mm2) Total PD-L1 at EOS (cells/mm2) Fold change in PD-L1
1 N NA* NA* NA* NA* NA* NA* NA* NA*
2 Y 635.31 410.79 0.65 2934.46 1542.39 0.22 0.27 1.23 74.40 104.21 8.54 3.94 0.46 5880.09 5818.34 0.99
3 Y 8.24 199.98 24.26 509.24 1102.63 0.02 0.18 11.20 8.24 28.73 1.00 6.96 6.96 1768.04 3645.96 2.06
4 N 91.74 66.00 0.72 1181.13 986.80 0.08 0.07 0.86 28.37 2.46 3.23 26.82 8.29 386.86 74.05 0.19
6 Y 97.57 458.59 4.7 1429.45 1018.55 0.07 0.45 6.60 62.04 142.56 1.57 3.22 2.05 2578.75 753.61 0.29
7 Y 50.77 78.90 1.55 2339.25 1236.81 0.02 0.06 2.94 56.91 44.63 0.89 1.77 1.98 5.01 139.03 27.73
8 N 159.44 277.12 1.74 1736.01 4983.88 0.09 0.06 0.61 158.59 77.30 1.01 3.59 3.57 6.80 295.57 43.48
10 N 78.94 24.96 0.32 504.38 3163.62 0.16 0.01 0.05 12.52 27.46 6.30 0.91 0.14 4258.22 6.39 0.001
11 Y 46.10 2444.31 53.02 2729.52 1792.39 0.02 1.36 80.74 2.46 406.59 18.74 6.01 0.32 281.36 2051.24 7.29
12 N 0.00 1626.32 >1626.32 2310.30 4750.41 NA 0.34 >0.34 2.52 351.85 NA 4.62 >4.62 6869.22 668.08 0.10
*

Slides from patient 1 did not contain enough tissue to complete the analysis